Content note: This article is intended solely for healthcare professionals and organisational decision-makers. It is not intended for patients or members of the public and does not provide individual medical advice.
At a glance
During 2026, the first pharmacists trained under the revised pathway are joining the GPhC register with independent prescribing included at registration. It does not mean that every pharmacist can prescribe in every setting, or that local governance and supervision requirements no longer apply.
Separately, NHS England is developing an expanded national prescribing offer in England from autumn 2026. It will introduce independent prescribing into national community pharmacy services, including extensions to Pharmacy First and the Pharmacy Contraception Service. These are related developments, but they should not be treated as the same rule.
What is independent prescribing?
Independent prescribing means that an appropriately qualified healthcare professional can assess a clinical presentation, make a prescribing decision and take responsibility for that decision within their competence and scope of practice.
For pharmacists, this builds on medicines expertise and requires more than knowledge of products. It also involves:
- clinical assessment and judgement
- documentation and monitoring
- referral when a presentation is outside scope
- collaboration with other healthcare professionals
- ongoing professional development.
Independent prescribers are already an important and growing part of the UK healthcare workforce. The Nuffield Trust reports that nearly 100,000 independent prescribers were recorded in the UK as of April 2025. It identifies pharmacists as the fastest-growing professional group, with 22,770 pharmacists holding an independent prescribing annotation in November 2025.
Key registration and service changes in 2026
The change follows the General Pharmaceutical Council’s revised initial education and training standards. Prescribing knowledge, skills and behaviours are now embedded across the pharmacy degree and supervised foundation training year. The first cohort trained under this pathway is joining the GPhC register with independent prescribing included at registration.
The practical distinction is important:
- Registration: newly qualified pharmacists trained under the revised pathway may enter the GPhC register as independent prescribers.
- Practice: each pharmacist must still work within individual competence, experience, scope and local governance arrangements.
- Service delivery: NHS commissioning and service specifications determine where prescribing can be used in practice.
The GPhC advice for newly qualified prescribing pharmacists highlights scope of practice, support and mentorship, prescribing decisions, indemnity, revalidation and employer responsibilities.
The NHS England and Health Education England information on independent prescribing identifies an appropriately qualified Designated Prescribing Practitioner, a suitable practice-based learning environment and clinical support as important elements of training routes in England. The information covers community, primary care, health and justice, hospital, mental health trust and ICB-employed pharmacists.
The registration and commissioning position may differ between England, Scotland, Wales and Northern Ireland. Organisations should check the requirements of the relevant regulator and national health service before changing their operating model.
Who is affected?
Newly qualified pharmacists
The new cohort will enter practice with prescribing incorporated into registration. However, the annotation should be viewed as the starting point of prescribing practice, not as evidence of unrestricted readiness across all clinical areas.
The Nuffield Trust identifies supervision, protected learning time, Continuing Professional Development (CPD) and suitable roles as important implementation requirements. It also warns that limited access to supervision could prevent pharmacists from using or developing their prescribing skills consistently.
Existing pharmacist prescribers
Existing prescribers will have an important role in supporting new colleagues through:
- structured induction
- case discussion and peer support
- supervision and escalation
- audit and reflective practice
- multidisciplinary working
Organisations should verify each pharmacist’s registration status, prescribing annotation, competence and local authorisation rather than relying on job title alone.
Pharmacy students, technicians and employers
For pharmacy students, prescribing becomes a more visible part of the transition from education into practice. For pharmacy technicians, the change concerns pharmacist registration, but it may affect workflow, information gathering, record keeping, supply and escalation processes.
Employers and senior leaders need to translate individual prescribing capability into safe service design. That includes workforce planning, digital access, supervision capacity, audit and clear communication between pharmacy, medical, nursing and procurement teams.
What it means for professional practice
The main message is simple: prescribing status is not the same as unrestricted prescribing readiness.
Organisations should ensure that:
- scope of practice is documented and reviewed
- newly qualified pharmacists have access to suitable supervision and mentorship
- clinical records and prescribing systems are available
- referral and escalation routes are clear
- prescribing activity is reviewed through audit, peer discussion and CPD
- indemnity arrangements cover the intended prescribing activity.
Implications for hospitals and procurement
The September change is not a procurement instruction. It does not require hospitals to change formularies, select a particular supplier or switch products.
For hospital pharmacy, procurement and medicines information teams, the priorities are operational:
- maintain current product, presentation and pack information
- connect prescribing activity with formulary and medicines governance
- clarify processes for supply disruption and alternative products
- ensure product identifiers, labelling and packaging information are communicated clearly
- separate clinical, regulatory and commercial information
- review whether new prescribing activity affects demand, stockholding or supply risk.
Manage your supply planning
As prescribing roles expand, teams will continue to need clear information about the products available within their local clinical and procurement frameworks. Parallel import suppliers such as Abacus Medicine can contribute to this information flow by providing current portfolio and supply details to pharmacies, hospitals and other healthcare organisations.
Explore supply options
FAQ
What is the difference between independent and supplementary prescribing?
Independent prescribers take responsibility for assessing a patient and making prescribing decisions within their professional competence. Supplementary prescribers work with a doctor or dentist and prescribe in accordance with an agreed, patient-specific clinical management plan.
Do all pharmacists qualify as independent prescribers?
Not all currently registered pharmacists are automatically independent prescribers. They must have the appropriate qualification and prescribing annotation on the professional register. From September 2026, newly qualified pharmacists will join the register as independent prescribers, while existing pharmacists can undertake approved independent-prescribing training.
How will independent prescribing change community pharmacy services?
Independent prescribing will allow suitably qualified pharmacists to assess patients and prescribe within their competence as part of a broader range of clinical services. NHS England is developing this role through Pharmacy First and its national prescribing offer, although the services available to patients will depend on local arrangements and whether an appropriately qualified prescriber is available.
Sources and further reading
The following sources were used for this article and offer further reading for those interested in the topic.
- NHS England, Pharmacy Quality Scheme 2026/27: clinical services audit.
- General Pharmaceutical Council, GPhC publishes advice for newly qualified prescribing pharmacists, published 10 June 2026.
- Nuffield Trust, Independent prescribing in the UK: workforce ambitions and implementation challenges, published 9 April 2026.
- General Pharmaceutical Council, Standards for the initial education and training of pharmacists.
- Health Education England / NHS England, Independent prescribing.
